Literature DB >> 6373931

Tumoricidal activity of human monocytes: evidence for cytolytic function distinct from that of NK cells.

E S Kleinerman, R B Herberman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6373931

Source DB:  PubMed          Journal:  J Immunol        ISSN： 0022-1767            Impact factor:   5.422


× No keyword cloud information.
  11 in total

1.  The effect of leucyl-leucine methyl ester on proliferation and Ig secretion of EBV-transformed human B lymphocytes.

Authors:  M Ohlin; L Danielsson; R Carlsson; C A Borrebaeck
Journal:  Immunology       Date:  1989-04       Impact factor: 7.397

2.  Natural killer cell function is not diminished in the healthy aged and is proportional to the number of NK cells in the peripheral blood.

Authors:  G J Ligthart; H R Schuit; W Hijmans
Journal:  Immunology       Date:  1989-11       Impact factor: 7.397

3.  Phase I/II study of recombinant interferon alpha and gamma in advanced progressive renal-cell carcinoma.

Authors:  P H de Mulder; F M Debruyne; M P Franssen; A D Geboers; S Strijk; A G Reintjes; W H Doesburg; O Damsma
Journal:  Cancer Immunol Immunother       Date:  1990       Impact factor: 6.968

4.  Potentiation of direct antitumor cytotoxicity and production of tumor cytolytic factors in human blood monocytes by human recombinant interferon-gamma and muramyl dipeptide derivatives.

Authors:  S Sone; G Lopez-Berestein; I J Fidler
Journal:  Cancer Immunol Immunother       Date:  1986       Impact factor: 6.968

5.  Induction of urinary interleukin-1 (IL-1), IL-2, IL-6, and tumour necrosis factor during intravesical immunotherapy with bacillus Calmette-Guérin in superficial bladder cancer.

Authors:  E C De Boer; W H De Jong; P A Steerenberg; L A Aarden; E Tetteroo; E R De Groot; A P Van der Meijden; P D Vegt; F M Debruyne; E J Ruitenberg
Journal:  Cancer Immunol Immunother       Date:  1992       Impact factor: 6.968

6.  Presence of activated lymphocytes in the urine of patients with superficial bladder cancer after intravesical immunotherapy with bacillus Calmette-Guérin.

Authors:  E C De Boer; W H De Jong; A P Van Der Meijden; P A Steerenberg; J A Witjes; P D Vegt; F M Debruyne; E J Ruitenberg
Journal:  Cancer Immunol Immunother       Date:  1991       Impact factor: 6.968

7.  Monocyte tumoricidal activity and tumor necrosis factor production in patients with malignant brain tumors.

Authors:  B P Barna; L R Rogers; M J Thomassen; G H Barnett; M L Estes
Journal:  Cancer Immunol Immunother       Date:  1991       Impact factor: 6.968

8.  Cytotoxicity by human adherent cells: oxygen-dependent and -independent cytotoxic reactions by different cell populations.

Authors:  K P van Kessel; M R Visser; J A van Strijp; J H van Kats-Renaud; J Verhoef
Journal:  Immunology       Date:  1986-06       Impact factor: 7.397

9.  Human lymphokine preparations which generate tumoricidal properties of human monocytes in vitro may be distinct from gamma interferon.

Authors:  E S Kleinerman; R H Wiltrout; R Zicht; I J Fidler
Journal:  Cancer Immunol Immunother       Date:  1985       Impact factor: 6.968

10.  Killing of alveolar macrophages and of monocytes that have responded to granulocyte-macrophage colony-stimulating factor by human lymphokine-activated killer cells.

Authors:  S Sone; N Inamura; S M Singh; A Okubo; H Yanagawa; M Nakanishi; T Ogura
Journal:  Jpn J Cancer Res       Date:  1989-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.